Evaluation of quality of life in chronic, progressing rheumatic diseases based on the example of osteoarthritis and rheumatoid arthritis
Authors Wysocka-Skurska I, Sierakowska M, KuĹ‚ak W
Received 30 June 2016
Accepted for publication 2 September 2016
Published 28 November 2016 Volume 2016:11 Pages 1741—1750
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Akshita Wason
Peer reviewer comments 2
Editor who approved publication: Dr Richard Walker
Izabela Wysocka-Skurska,1 Matylda Sierakowska,2 Wojciech KuĹ‚ak3
1Department of Rheumatology and Internal Diseases, University Hospital in Bialystok, 2Department of Integrated Medical Care, Medical University of Bialystok, 3Clinic Rehabilitation Center for Children with Early Help Disabled Children “Give a Chance”, Medical University of Bialystok, Bialystok, Poland
Background: Rheumatic diseases, irrespective of etiology and clinical course, influence different areas of a patient’s life. Adapting to disability and limitations caused by an illness is very difficult for many patients. The main goal of a therapeutic procedure should be improvement of health-related quality of life (QoL).
Objective: Evaluation of the factors that influence the QoL that are conditioned by the state of health of patients with osteoarthritis (OA) and rheumatoid arthritis (RA).
Methods: The study group consisted of 198 patients diagnosed with OA, according to the American College of Rheumatology criteria (1988), and 100 patients diagnosed with RA, according to the American College of Rheumatology criteria (2010). A diagnostic survey using visual analog scale of pain, health assessment questionnaire disability index, and 36-item short form health survey were used in this study.
Results: The average age of patients with OA was 59.16 (±15.87) years and patients with RA was 55.22 (±14.87) years. The average duration of illness examined for OA was 5.5 (±4.32) years, whereas for RA, it was slightly more at 6.8 (±5.21) years. Overall the QoL in both study groups was of medium level. Among patients with OA and RA, lower evaluation of QoL was mainly affected by age (OA – physical sphere [PCS] rs=-0.177, P<0.012; MCS rs=-0.185, P=0.008; RA – PCS rs=-0.234, P=0.019; MCS rs=-0.208, P=0.038), the level of physical disability (OA – PCS rp=-0.532, P<0.001; MCS rs=-0.467, P<0.001; RA – PCS rp=-0.326, P<0.001; MCS rs=-0.229, P<0.001), and pain (OA – PCS rp=-0.425, P<0.001; mental sphere/mental functioning (MCS) rs=-0.359, P<0.001; RA – PCS rp=-0.313, P<0.001; MCS rp=-0.128, P<0.001).
Conclusion: Patients with OA, despite their average older age, had a higher evaluated QoL than patients with RA. Overall QoL in terms of mental functioning in both rheumatic diseases was assessed at a higher level than in the area of physical functioning.
Keywords: quality of life, physical functioning, mental functioning, pain, malfunction
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]